MedPath

ZERIT - CAP 40MG

ZERIT - CAP 40MG

Discontinued
DIN Number

02216116

Drug Class

Human

Market Date

Jul 30, 1996

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02216116
AIG Number0128554001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AF04 STAVUDINE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

STAVUDINEActive
Strength: 40 MG
Monograph: STAVUDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.